2020 review – Pharma’s progress outside of COVID-19
pharmaphorum
DECEMBER 23, 2020
NT-814 is a non-hormonal drug that works on the neurokinin (NK) 1,3 receptor antagonist, thus treating the vasomotor symptoms associated with the menopause. It was the third approval from Alnylam’s pipeline of RNA interference therapeutics to make it to market.
Let's personalize your content